Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer

Genes Chromosomes and Cancer

Volumn 21, Issue 2, 1998, Pages 152-159

  Huang, Haojie ^a   Qian, Chiping ^a   Jenkins, Robert B ^a   Smith, David I ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CONTIG; DNA;

ANIMAL CELL; ARTICLE; BREAST CANCER; CHROMOSOME 7Q; CHROMOSOME BAND; CHROMOSOME FRAGILE SITE; CLONE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; HAMSTER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HYBRID CELL; METAPHASE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; YEAST ARTIFICIAL CHROMOSOME;

EID: 0031892622     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199802)21:2<152::AID-GCC11>3.0.CO;2-T     Document Type: Article

References (52)

1. Barbi G, Steinbach P, Vogel W (1984) Nonrandom distribution of methotrexate-induced aberrations on human chromosomes: Detection of further folie acid sensitive fragile sites. Hum Genet 68:290-294.
2. Bellanne-Chantelot C, Lacroix B, Qugen R Billault A, Beautils S, Bertraut S, Georges I, Gilbert F, Lucotte G, Susm I, Jean-Jacques C, Gesnouin P, Pook S, Vaysseix G, Lu-Kuo J, Ried T, Ward D, Chumakov I, Le Paslier D, Barillot E, Cohen D (1992) Mapping the whole human genome by fingerprinting yeast artificial chromosomes. Cell 70:1059-1068.
3. Berger R, Bloomfield CD, Sutherland GR (1985) Report of the committee on chromosome rearrangements on neoplasia and on fragile sites (HGM8). Cytogenet Cell Genet 40:490-535.
4. Boldog FC, Wagoner B, Glover TW, Chumakov I, le Paslier D, Cohen D, Gemmill RM, Drabkin HA (1994) Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B. Genes Chromosomes Cancer 11:216-221.
5. Boldog FC, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA (1997) Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 6:193-203.
6. Breen M, Arveiler B, Murray I, Gosden JR, Porteous DJ (1990) YAC mapping by FISH using Alu-PCR-generated probes. Genomics 13:726-730:
7. Champeme M-H, Bieche I, Beuzelin M, Lidereau R (1995) Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis. Genes Chromosomes Cancer 12:304-306.
8. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tasai S, Jacobs SC, Brown RS (1979) Hereditary renal cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592-595.
9. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
10. Devilee P, Hermans J, Eyfjord J, Borresen A-L, Lidereau R, Sobol H, Borg A, Cleton-Jansen A-M, Olah E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon Y-J, Maugard CH, the Breast Cancer Somatic Genetics Consortium (1997) Loss of heterozygosity at 7q31 in breast cancer: Results from an international collaborative study group. Genes Chromosomes Cancer 18:193-199.
11. Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards R, Verkerk AJMH, Holden JJA, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
12. Glover TW, Berger C, Coyle-Morris J, Echo B (1984) DNA polymerase inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:882-890.
13. Glover TW, Stein CK (1988) Chromosome breakage and recombination at fragile sites. Am J Hum Genet 43:265-273.
14. Green ED, Mohr RM, Idol JR, Jones M, Buckingham JM, Deaven L, Moyzis RK, Olson MV (1991) Systematic generation of sequence-tagged sites for physical mapping of human chromosomes: Application to the mapping of human chromosome 7 using yeast artitical chromosomes. Genomics 11:548-564.
15. Hirsch B (1991) Sister chromid exchanges are preferentially induced at expressed and nonexpressed common fragile sites. Hum Genet 87:302-306.
16. Jones NJ, Stewart SA, Thompson LH (1990) Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells. Mutagenesis 5:15-23.
17. Jones C, Slijepcevic P, March S, Baker E, Langdon WY, Richards RI, Tunnacliffe A (1994) Physical linkage of the fragile site FRA11B and Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 3:2123-2130.
18. Kastury K, Baffa R, Druck T, Ohta M, Cotticelli MG, Inoue H, Negrini M, Rugge M, Huang D, Croce CM, Palazzo J, Huebner K (1997) Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res 56:978-983.
19. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, Pointon J, Middleton-Price HR, Barnicoat A, Pembrey ME (1993) Tri-nucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-134.
20. Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N, Koeffler HP (1997) Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosomes Cancer 19:1-5.
21. Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Kitahara K, Fujii K, Tahara E (1994) Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas. Int J Cancer 59:597-600.
22. Kuwano A, Murano I, Kajii T (1990) Cell type-dependent difference in the distribution and frequency of excess thymidine-induced common fragile sites: T lymphocytes and skin fibroblasts. Hum Genet 84:527-531.
23. Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Le Duc A, Rouesse J, Lidereau R (1995) Genetic alterations in localized cancers of the prostate: Identification of a common region of deletion on the chromosome 18q. Bull Cancer 82:589-597.
24. Ledbetter SA, Garcia-Heras J, Ledbetter DH (1990) "PCR-karyotype" of human chromosomes in somatic cell hybrids. Genomics 8:614-622.
25. Lin JC, Scherer SW, Tongas L, Traverso G, Tsui L-C, Andrulis I, Jothy S, Park M (1996) Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. Oncogene 13:2001-2008.
26. Muleris M, Almeida A, Dutrillaux AM, Prochon E, Vega F, Delattre JY, Poisson M, Malfoy B, Dutrillaux (1994) Oncogene amplification in human gliomas: A molecular cytogenetic analysis. Oncogene 9:2717-2722.
27. Nancrarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, le Paslier D, Callen DF, Sutherland GR, Richards RI (1994) Implication of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science 264:1938-1941.
28. Nelson DL, Ledbetter SA, Corbo L, Victoria MF, Ramirez-Solis R, Webster TD, Ledbetter DH, Caskey CT (1989) Alu polymerase chain reaction: A method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci USA 86:6686-6690.
29. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
30. Pandis N, Bardi G, Mitelman F, Heim S (1997) Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 18:241-245.
31. Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge A, Glover TW, Smith DI (1996) A 350-kb cosmid contig in 3p14.2 that cross the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics 35:87-93.
32. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
33. Rassool FV, Le Beau MM, Neilly ME, van Melle E, Espinosa R 3d, McKeithan TW (1992) Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am J Hum Genet 50:1243-1251.
34. Ritchie RJ, Knight SJL, Hirst MC, Crewal PK, Bobrow M, Cross GS, Davies KE (1994) The cloning of FRAXF: Trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter. Hum Mol Genet 3:2115-2121.
35. Seruca R, Suijkerbuik RF, Gartner F, Criado B, Veiga I, Olde-Weghuis D, David L, Castedo S, Sobrinho-Simoes M (1995) Increased levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet 82:104-145.
36. Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Wilke C, Glover TW, Vaitkevicius VK, Smith DI (1997a) Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res 56:4347-1350.
37. Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI (1997b) Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene, In Press.
38. Smeets DFCM, Scheres JMJC, Hustinx TWJ (1986) The most common fragile site in man is 3p14. Hum Genet 72:215-220.
39. Sutherland GR, Ledletter DH (1989) Report of the committee on cytogenetic markers. Cytogenet Cell Genet 51:452-458.
40. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB (1995) Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55:4114-4119.
41. Verkerk AJMH, Pieretti, Sutcliffe JS, Fu Y-H, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst GH, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
42. Wang YH, Gellibolian R, Shimizu M, Wells RD, Griffith J (1996) Long CCG triplet repeat blocks exclude nucleosomes: A possible mechanism for the nature of fragile sites in chromosomes. J Mol Biol 263:511-516.
43. Wilke CM, Guo S-W, Hall BK, Boldog F, Gemmill RM, Chandrasekharappa SC, Barcroft CL, Drabkin HA, Grover TW (1994) Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the 7(3;8) associated with renal cell carcinoma. Genomics 22:319-326.
44. Wullich B, Sattler HP, Fisher U, Meese E (1994) Two independent amplification events on chromosome 7 in glioma: Amplification of rhe epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14:577-579.
45. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richard RI (1991) Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-1181.
46. Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, Eyre H, Lapsys N, le Paslier D, Doggett NA, Sutherland GR, Richards RI (1997) Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88:367-374.
47. Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226:1199-1204.
48. n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 91:12155-12158.
49. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ (1994b) Loss of heterozygosity in human prostate carcinomas: A possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373.
50. Zenklusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ (1995a) Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 1q31.1: Evidence for a broad range tumor suppressor gene. Cancer Res 55:1347-1350.
51. Zenklusen J, Weitzel J, Ball H, Conti C (1995b) Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oneogcne 11:359-363.
52. Zimonjic DB, Druck T, Ohta M, Kastury K, Carlo MC, Popescu NC (1997) Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FIHT gene. Cancer Res 57:1166-1170.